Al. Heroux et al., HEART-TRANSPLANTATION AS A TREATMENT OPTION FOR END-STAGE HEART-DISEASE IN PATIENTS OLDER THAN 65 YEARS OF AGE, The Journal of heart and lung transplantation, 12(4), 1993, pp. 573-579
Because of the critical donor organ shortage for heart transplantation
, selection of recipients should be based on the potential for maximum
benefit. To evaluate the effects of advancing age on outcome after he
art transplantation, we compared the clinical variables of 12 recipien
ts aged 65 years or older (66.1 +/- 0.9 years x +/- standard deviatio
n!; range, 65 to 67 years) with those of 57 patients aged 55 to 64 yea
rs (59.3 +/- 2.7 years) at the time of the procedure. The two study gr
oups were similar in sex, race, pretransplantation heart disease, immu
nocompatibility, maintenance immunosuppression, and length of first ho
spitalization at the time of the procedure. Groups were also similar r
egarding the incidence of malignancies, fractures, diabetes, neurologi
c complications, and renal dysfunction occurring over the follow-up pe
riod. Patients 65 years of age or older had a significantly higher num
ber of hospital days (36 +/- 29 versus 15 +/- 18 days; p < 0.02) and i
ncreased frequency of infections/month (0.7 +/- 0.3 versus 0.3 +/- 0.4
infections/month; p < 0.03) during the first postoperative year. Olde
r patients had a higher incidence of cytomegalovirus infections (50% v
ersus 19%; p < 0.06), lower rates of rejection at 1 and 6 months after
operation (p < 0.03), and more severe functional limitation (p < 0.00
2) than patients aged 55 to 64 years. One-year actuarial survival was
not significantly different in the two groups. The results of our stud
y suggest that, because of lower rejection and higher infection rates,
heart transplantation recipients older than 65 years of age should re
ceive less intense immunosuppression. Because after heart transplantat
ion patients 65 years of age and older do not improve functionally as
dramatically as younger patients, age-related comorbidities that may a
dversely affect outcome. should be carefully evaluated when considerin
g older patients for heart transplantation.